Patients Reuters Pharma USA – Ligia Del Bianco At Reuters Pharma USA last month in Philadelphia, centring the voice of the patient was a major topic of discussion throughout the event.
Events Partner Content 2nd Gene Therapy for Neurological Disorders Europe Maximising the Opportunity in CNS Gene Therapies
News Biogen go quantum to speed up drug development Quantum computing algorithm could lead to new neurological disease drugs.
News Lundbeck enlists IBM Watson to aid psychiatric drug research Collaboration will initially focus on Parkinson's disease and schizophrenia.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
